Academy of Military Medical Sciences

In October 2011, the drug "Night Eagle", developed to help soldiers cope with sleep deprivation during missions, was unveiled in an exhibition marking the institute's 60th anniversary.

[4] In December 2014, the Chinese government announced that the Academy of Military Medical Sciences had developed an Ebola virus vaccine candidate that had been approved for clinical trials.

[1][2] In December 2021, the United States Department of Commerce added the Academy of Military Medical Sciences to the Entity List, accusing it of aiding in the persecution of Uyghurs in China.

[6][7] It conducted its Phase III trials in Argentina,[8] Chile,[9] Mexico,[10] Pakistan,[11] Russia,[12] and Saudi Arabia[13] with 40,000 participants.

[17] Its single-dose regimen and standard refrigerator storage requirement (2°to 8 °C) could make it a favorable vaccine option for many countries.